Subcutaneous drugs grant a new lease on life to checkpoint inhibitors – Pharmaceutical Technology
As per Roche, Tecentriq SC can be administered in seven minutes compared to 30–60 minutes for the intravenous formulation. Image Credit: CI Photos / Shutterstock.